本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 1998/5/291 分钟阅读
Oral Dosage Form New Animal Drugs; Milbemycin Oxime Tablet
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Novartis Animal Health US, Inc. The supplemental NADA provides for expanding the indications to include separate dosage and labeling for use of milbemycin oxime in cats.
来源原始语言: Federal Register — Food and Drug Administration打开原始公告 →